[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 294,828
  • Shares Outstanding, K 13,383
  • Annual Sales, $ 112,820 K
  • Annual Income, $ -10,880 K
  • EBIT $ -5 M
  • EBITDA $ 1 M
  • 60-Month Beta 0.20
  • Price/Sales 2.52
  • Price/Cash Flow N/A
  • Price/Book 2.02

Options Overview Details

View History
  • Implied Volatility 60.56% (+7.18%)
  • Historical Volatility 59.60%
  • IV Percentile 9%
  • IV Rank 8.16%
  • IV High 435.67% on 01/23/26
  • IV Low 27.25% on 09/09/25
  • Expected Move (DTE 8) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 380
  • Open Int (30-Day) 199
  • Expected Range 22.03 to 22.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.02
  • Number of Estimates 1
  • High Estimate $0.02
  • Low Estimate $0.02
  • Prior Year $-0.17
  • Growth Rate Est. (year over year) +111.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.58 +51.10%
on 07/24/26
22.88 -3.72%
on 08/10/26
+6.43 (+41.22%)
since 07/10/26
3-Month
13.77 +59.99%
on 06/22/26
22.88 -3.72%
on 08/10/26
+7.35 (+50.07%)
since 05/12/26
52-Week
8.22 +167.99%
on 08/21/25
22.88 -3.72%
on 08/10/26
+13.31 (+152.64%)
since 08/12/25

Most Recent Stories

More News
Anika: Q2 Earnings Snapshot

Anika: Q2 Earnings Snapshot

ANIK : 22.03 (+3.77%)
Anika Reports Second Quarter 2026 Financial Results

Commercial Channel Revenue Increased 17% to a Record $13.9 Million Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020 Raising Full-Year...

ANIK : 22.03 (+3.77%)
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

ANIK : 22.03 (+3.77%)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early...

ANIK : 22.03 (+3.77%)
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

AXGN : 49.67 (+2.45%)
TELA : 0.7202 (-8.84%)
ANIK : 22.03 (+3.77%)
MDXG : 4.26 (-0.47%)
ELUT : 0.8180 (+2.06%)
BVS : 13.84 (-0.54%)
Anika: Q1 Earnings Snapshot

Anika: Q1 Earnings Snapshot

ANIK : 22.03 (+3.77%)
Anika Reports First Quarter 2026 Financial Results

Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel order timing Delivered 64% gross margin, +8 points year over year, driven by improved operational execution...

ANIK : 22.03 (+3.77%)
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people...

ANIK : 22.03 (+3.77%)
XLO : 9.08 (+0.33%)
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026

BEDFORD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

ANIK : 22.03 (+3.77%)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early...

ANIK : 22.03 (+3.77%)

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

3rd Resistance Point 24.51
2nd Resistance Point 23.37
1st Resistance Point 22.70
Last Price 22.03
1st Support Level 20.89
2nd Support Level 19.75
3rd Support Level 19.08

See More

52-Week High 22.88
Last Price 22.03
Fibonacci 61.8% 17.28
Fibonacci 50% 15.55
Fibonacci 38.2% 13.82
52-Week Low 8.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.